Claremont Biosolutions specializes in advanced technologies for biological sample processing and assay development. Their OmniLyse® Inside Cell Lysis Kits provide efficient solutions for lysis, homogenization, and extraction of various biomolecules, including genomic DNA (gDNA), RNA, and proteins. The SimplePrep® Automated Extraction Platform further enhances this process by enabling automated lysis and gDNA extraction within a single disposable cartridge, streamlining workflows and improving efficiency in laboratory settings. Additionally, the company offers a range of manual kits and columns designed for various extraction and purification needs.

In the realm of point-of-care diagnostics, Claremont Biosolutions provides innovative tools such as the Automated Lateral Flow Reagent Dispenser and a comprehensive Core Assay Development Starter Kit. The starter kit includes essential components for developing and optimizing lateral flow assays, which are crucial for rapid diagnostic tests. This all-in-one package eliminates the need for multiple vendors, allowing researchers to efficiently create and refine their assays. Overall, Claremont Biosolutions' technologies cater to both laboratory and field applications, enhancing the capabilities of researchers and healthcare professionals in the life sciences.

United States

Claremont BioSolutions is a privately held, emerging growth technology company specializing in miniaturized, disposable devices that provide solutions to what is recognized as the "bottleneck" of DNA diagnostics – sample preparation. The company has developed proprietary disposable devices which employ micro-motors to perform very efficient mechanical tissue homogenization, cell lysis, and nucleic acid purification. Their efforts toward solving sample prep challenges with hard to handle sample matrices and pathogens have led the company to its development of unique reagents and buffers that are of broad interest in the diagnostics industry.

Claremont Biosolutions

Company Details